Michael W. Kalb - Executive Vice President & CFO at CATALYST PHARMACEUTICALS, INC.

Insider Transactions and Holdings

Entity Type
Individual
Role
Executive Vice President & CFO
Issuer Symbol
CPRX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Michael W. Kalb since 11 Mar 2025

Holdings reported by Michael W. Kalb for CATALYST PHARMACEUTICALS, INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 632,903 $1,907,553 $4.01 05 Jan 2026 Direct Common Stock
Common Stock, par value $0.001 per share 13,665 $318,942 $23.34 05 Jan 2026 Direct
Options to purchase common stock 607,235 20 Nov 2025 Direct Common Stock

Transactions reported by Michael W. Kalb for CATALYST PHARMACEUTICALS, INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.